Cassandra Pardini, PharmD

Contributing Writer https://www.rheumatologyadvisor.com

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

Systemic Lupus Erythematosus

Newly Diagnosed SLE Could Potentially Be Drug Induced

Cassandra Pardini, PharmD

September 18, 2020

A new case of cutaneous lupus erythematosus or systemic lupus erythematosus could potentially be drug induced.

General Rheumatology

Patients With COVID-19 With High Inflammation Levels May Benefit From Steroid Therapy

Cassandra Pardini, PharmD

July 30, 2020

Early treatment with glucocorticoids may be beneficial for patients hospitalized with COVID-19 who have high levels of inflammation due to the disease.

General Rheumatology

Clinical Benefit Observed With Colchicine in Hospitalized Patients With COVID-19

Cassandra Pardini, PharmD

June 30, 2020

Colchicine could potentially play a role in the treatment of hospitalized patients with COVID-19.

Practice Management

Prescription Patterns Examined During COVID-19 Pandemic

Cassandra Pardini, PharmD

June 2, 2020

Prescription fill patterns of medications associated with potential benefits, as well as possible harms, during the COVID-19 pandemic described in new analysis.

Pediatric Rheumatology

Immune Globulin Therapy Linked to Heart Function Recovery in COVID-Related Multisystem Inflammatory Syndrome

Cassandra Pardini, PharmD

May 26, 2020

The use of immune globulin therapy appears to benefit children who experience acute heart failure caused by coronavirus disease 2019 (COVID-19)-related multisystem inflammatory syndrome, according to the findings of a case series recently published in Circulation.

General Rheumatology

NIH Treatment Guidelines for COVID-19 Released

Cassandra Pardini, PharmD

April 30, 2020

Recommendations on the management of COVID-19 were recently released by the NIH to help guide clinicians caring for patients with COVID-19.

Gout

Commonly Used Gout Treatments Increase Risk for Hypersensitivity Reactions

Cassandra Pardini, PharmD

February 28, 2020

Allopurinol and febuxostat were found to be associated with a higher risk of hypersensitivity reactions when compared to colchicine, according to the results of a recently published population-based study.

Rheumatoid Arthritis

Successful Treatment of Long-Term Eosinophilic Esophagitis With JAK Inhibitor

Cassandra Pardini, PharmD

January 13, 2020

Several treatments were attempted but failed to manage the patient’s conditions, including proton pump inhibitors, topical steroids, a restricted diet, and infliximab (3 doses) for arthritis.

Psoriatic Arthritis

Case Highlights Novel Approach to Treatment of Ulcerative Colitis, Psoriatic Arthritis

Cassandra Pardini, PharmD

December 23, 2019

A recently published report presented at the 2019 AIBD Annual Meeting in Orlando, FL, discussed the case of a patient who developed ulcerative colitis (UC) following treatment with Secukinumab for her psoriatic arthritis and highlighted a novel approach for the management of both of her conditions simultaneously.

Gout

Methylprednisolone Beneficial as Pre-Infusion Prophylaxis Therapy in Patients Receiving Pegloticase for Gout

Cassandra Pardini, PharmD

November 28, 2019

Compared with intravenous hydrocortisone, IV methylprednisolone appears to be more beneficial as a pre-infusion prophylaxis therapy in patients receiving pegloticase, according to the findings of a recently published review.

Next post in Gout